A detailed history of Mediolanum International Funds LTD transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Mediolanum International Funds LTD holds 92,612 shares of BMY stock, worth $5.48 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares
92,612
Previous 88,527 4.61%
Holding current value
$5.48 Million
Previous $4.5 Billion 15.1%
% of portfolio
0.07%
Previous 0.06%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 23, 2025

BUY
$51.92 - $59.94 $212,093 - $244,854
4,085 Added 4.61%
92,612 $5.18 Billion
Q3 2024

Oct 23, 2024

BUY
$39.66 - $51.75 $19,195 - $25,047
484 Added 0.55%
88,527 $4.5 Billion
Q2 2024

Aug 13, 2024

SELL
$40.25 - $52.99 $5.88 Million - $7.74 Million
-145,993 Reduced 62.38%
88,043 $3.41 Billion
Q1 2024

May 03, 2024

BUY
$47.98 - $54.4 $11.2 Million - $12.7 Million
234,036 New
234,036 $12.5 Billion

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $126B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Mediolanum International Funds LTD Portfolio

Follow Mediolanum International Funds LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mediolanum International Funds LTD, based on Form 13F filings with the SEC.

News

Stay updated on Mediolanum International Funds LTD with notifications on news.